ペンシルベニアにおける片頭痛の臨床試験
ペンシルベニア内の拠点で、片頭痛に関する8件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital of Philadelphia, Philadelphia
被験者募集中第1相
6歳〜11歳 · 全性別 · 2026/09/28更新 · NCT06995729MMA Embolization for Refractory Chronic Migraine
- Thomas Jefferson University Hospital, Philadelphia
被験者募集中
18歳〜65歳 · 全性別 · 2026/09/25更新 · NCT06735833Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Clario, Philadelphia
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- The Children's Hospital of Philadelphia /ID# 270842, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 270854, Scottdale
- Frontier Clinical Research - Smithfield /ID# 270849, Smithfield
被験者募集中第3相
12歳〜17歳 · 全性別 · 2026/09/22更新 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Children's Hospital of Philadelphia, Philadelphia
被験者募集中
10歳〜17歳 · 全性別 · 2026/09/21更新 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- University of Pennsylvania, Philadelphia
被験者募集中第4相
18歳〜70歳 · 全性別 · 2026/09/16更新 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Children's Hospital of Philadelphia - Main /ID# 232487, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 231913, Scottdale
- Frontier Clinical Research - Smithfield /ID# 231912, Smithfield
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/14更新 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Lehigh Center for Clinical Research, Allentown
- Clinical Research Philadelphia, Philadelphia
- Preferred Primary Care Physicians, Inc., Pittsburgh
- 他2件
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/20更新 · NCT07645924ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。